NEW YORK – Create Medicines has started clinically testing an in vivo CAR therapy that comprises a cancer-killing medley of T, NK, and myeloid cells.
A Mayo Clinic-led study found that high-dose vitamin D supplementation in inflammatory bowel disease (IBD) patients with low vitamin D levels was associated with increased protective IgA tagging and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results